News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,247 Results
Type
Article (14242)
Company Profile (108)
Press Release (258894)
Multimedia
Podcasts (63)
Webinars (13)
Section
Business (88462)
Career Advice (466)
Deals (15417)
Drug Delivery (70)
Drug Development (36992)
Employer Resources (50)
FDA (6378)
Job Trends (6242)
News (151123)
Policy (14175)
Tag
Academia (468)
Accelerated approval (7)
Adcomms (7)
Allergies (61)
Alliances (23372)
ALS (53)
Alzheimer's disease (463)
Antibody-drug conjugate (ADC) (84)
Approvals (6508)
Artificial intelligence (177)
Autoimmune disease (27)
Automation (9)
Bankruptcy (150)
Best Places to Work (4384)
BIOSECURE Act (9)
Biosimilars (100)
Biotechnology (40)
Bladder cancer (34)
Brain cancer (26)
Breast cancer (137)
Cancer (1137)
Cardiovascular disease (134)
Career advice (416)
Career pathing (13)
CAR-T (39)
CDC (6)
Cell therapy (130)
Cervical cancer (8)
Clinical research (31925)
Collaboration (601)
Compensation (284)
Complete response letters (30)
COVID-19 (860)
CRISPR (40)
C-suite (346)
Cystic fibrosis (55)
Data (1556)
Denatured (18)
Depression (31)
Diabetes (120)
Diagnostics (1385)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (99)
Drug pricing (106)
Drug shortages (12)
Duchenne muscular dystrophy (73)
Earnings (33479)
Editorial (17)
Employer branding (4)
Employer resources (45)
Events (38837)
Executive appointments (514)
FDA (7319)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (370)
Gene editing (63)
Generative AI (13)
Gene therapy (150)
GLP-1 (424)
Government (1406)
Grass and pollen (4)
Guidances (160)
Healthcare (3673)
HIV (9)
Huntington's disease (6)
IgA nephropathy (33)
Immunology and inflammation (63)
Immuno-oncology (5)
Indications (36)
Infectious disease (917)
Inflammatory bowel disease (70)
Inflation Reduction Act (7)
Influenza (21)
Intellectual property (95)
Interviews (60)
IPO (5941)
IRA (34)
Job creations (2056)
Job search strategy (374)
Kidney cancer (9)
Labor market (27)
Layoffs (205)
Leadership (8)
Legal (3452)
Liver cancer (21)
Longevity (7)
Lung cancer (165)
Lymphoma (99)
Machine learning (9)
Management (17)
Manufacturing (338)
MASH (64)
Medical device (1326)
Medtech (1329)
Mergers & acquisitions (9842)
Metabolic disorders (397)
Multiple sclerosis (49)
NASH (14)
Neurodegenerative disease (64)
Neuropsychiatric disorders (23)
Neuroscience (817)
NextGen: Class of 2025 (1600)
Non-profit (609)
Now hiring (16)
Obesity (202)
Opinion (137)
Ovarian cancer (34)
Pain (92)
Pancreatic cancer (43)
Parkinson's disease (68)
Partnered (9)
Patents (194)
Patient recruitment (91)
Peanut (13)
People (29590)
Pharmaceutical (63)
Pharmacy benefit managers (15)
Phase I (8289)
Phase II (13518)
Phase III (12150)
Pipeline (1320)
Policy (125)
Postmarket research (1401)
Preclinical (3380)
Press Release (25)
Prostate cancer (77)
Psychedelics (14)
Radiopharmaceuticals (127)
Rare diseases (282)
Real estate (2656)
Recruiting (18)
Regulatory (10739)
Reports (15)
Research institute (597)
Resumes & cover letters (55)
Rett syndrome (3)
RNA editing (5)
RSV (18)
Schizophrenia (61)
Series A (67)
Series B (39)
Service/supplier (3)
Sickle cell disease (42)
Special edition (10)
Spinal muscular atrophy (78)
Sponsored (8)
Startups (1644)
State (2)
Stomach cancer (4)
Supply chain (43)
Tariffs (66)
The Weekly (43)
Vaccines (233)
Venture capital (27)
Weight loss (131)
Women's health (16)
Worklife (4)
Date
Today (49)
Last 7 days (223)
Last 30 days (1182)
Last 365 days (10859)
2025 (9963)
2024 (12586)
2023 (14360)
2022 (19742)
2021 (20339)
2020 (19244)
2019 (14955)
2018 (11750)
2017 (13929)
2016 (13146)
2015 (15488)
2014 (12423)
2013 (10592)
2012 (11395)
2011 (11927)
2010 (10890)
Location
Africa (322)
Alabama (17)
Alaska (2)
Arizona (71)
Arkansas (3)
Asia (20783)
Australia (2675)
California (2853)
Canada (1363)
China (456)
Colorado (125)
Connecticut (124)
Delaware (109)
Europe (40731)
Florida (541)
Georgia (59)
Hawaii (1)
Idaho (10)
Illinois (301)
India (36)
Indiana (215)
Iowa (1)
Japan (195)
Kansas (75)
Kentucky (19)
Louisiana (3)
Maine (2)
Maryland (393)
Massachusetts (2399)
Michigan (43)
Minnesota (150)
Mississippi (1)
Missouri (31)
Montana (8)
Nebraska (6)
Nevada (16)
New Hampshire (6)
New Jersey (1265)
New Mexico (8)
New York (843)
North Carolina (562)
North Dakota (2)
Northern California (1259)
Ohio (70)
Oklahoma (5)
Oregon (17)
Pennsylvania (661)
Puerto Rico (10)
Rhode Island (15)
South America (508)
South Carolina (8)
Southern California (1244)
Tennessee (50)
Texas (405)
United States (11570)
Utah (55)
Virginia (143)
Washington D.C. (41)
Washington State (196)
West Virginia (1)
Wisconsin (31)
Wyoming (1)
273,247 Results for "rxi pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
INTASYL Compound RXI-231: a promising approach to treatment of hyperpigmentation
January 2, 2025
·
5 min read
Policy
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
Phio’s Compound RXI-185 is designed to slow progression of UV induced collagen breakdown
June 18, 2024
·
4 min read
Genetown
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Phio Pharmaceuticals Corp. announced that the United States Patent and Trademark Office has granted patent application 17/150,614 for two of its INTASYL Compounds, RXI-185 and RXI-231.
March 6, 2024
·
4 min read
Sponsored
Best Pharmaceutical Label Manufacturers: Reviews and Comparisons
Selecting the ideal pharmaceutical label manufacturer requires careful consideration. This article compares leading companies, highlighting their strengths in regulatory compliance, material performance, serialization, innovation, and sustainability, to help you make an informed decision for your product’s safety and success.
October 27, 2025
·
6 min read
Press Releases
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
November 11, 2025
·
7 min read
Press Releases
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in on-going clinical study
May 16, 2025
·
9 min read
Press Releases
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
November 5, 2025
·
1 min read
Press Releases
CASI Pharmaceuticals Announces Changes in Board Governance
November 20, 2025
·
7 min read
Press Releases
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
November 19, 2025
·
8 min read
Press Releases
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer’s disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026
September 23, 2025
·
12 min read
1 of 27,325
Next
